research

ASCO Quality Care Symposium; #ASCOQLTY22
September 26, 2022
Brielle Gregory Collins, ASCO staff

Effects of Patient Navigation, Lower-Cost Drug Alternatives on the Cost of Cancer Care and Rates of Metastatic Cancer Diagnoses and Deaths After Medicaid Expansion: Research from the 2022 ASCO Quality Care Symposium

English
Brielle.Gregory.Collins

Read research from the 2022 ASCO Quality Care Symposium, including studies on how cancer navigation programs and lower-cost drug alternatives can lower the cost of care and a study on how Medicaid expansion affected the rates of metastatic cancer diagnoses and cancer deaths.

Read More >>
August 10, 2022
Christopher Flowers, MD, MS, FASCO; Vicki Keedy, MD; Daniel Mulrooney, MD, MS; and Sumanta (Monty) Pal, MD, FASCO

What to Know About Peer-Reviewed Cancer Information and Its Role in Cancer Research

English
Christopher.Flowers.Vicki.Keedy.Daniel.Mulrooney.Sumanta.Pal

In this post, several experts describe the importance of peer-reviewed cancer information, including what “peer reviewed” means, what to know about levels of scientific evidence in cancer research, and the differences between research done in cell lines, animals, and humans.

Read More >>
2022 ASCO Annual Meeting; #ASCO22
June 7, 2022
Brielle Gregory Collins, ASCO staff

2022 ASCO Annual Meeting: Using Biomarker Testing to Avoid Radiation Therapy in People 55+ With Luminal A Breast Cancer

English
Brielle.Gregory.Collins

The ASCO Annual Meeting is being held June 3 to 7, and here is some of notable research that will be presented today. Today’s research includes a study evaluating whether radiation therapy can be avoided after surgery for people aged 55 or older with low-grade luminal A breast cancer, as identified through biomarker testing.

Read More >>

Pages

Subscribe to RSS - research